Description:
- Contains the active ingredient Nimotuzumab.
- Monoclonal antibody used in cancer treatment.
- Approved for the treatment of head and neck cancer, as well as certain types of brain cancer.
- Typically used with other cancer treatments such as chemotherapy and radiation therapy.
Uses:
- Head and neck cancer.
- Certain types of brain cancer.
- Esophageal cancer.
Therapeutic Effects:
- Targets and binds to the epidermal growth factor receptor (EGFR) found on many cancer cells.
- Blocks the growth and spread of cancer cells.
- Targeted therapy approach minimizes damage to healthy cells.
Interaction with Other Drugs:
- Inform your healthcare provider about all the medicines you take.
- Certain medications may interact with Biomab EGFR 50mg Injection and reduce effectiveness.
Storage:
- Store in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F).
- Do not freeze.
- Once a vial is opened, it should be used immediately.
- If not used immediately, it can be stored at room temperature for 4 hours. After 4 hours, any remaining drug should be discarded.
- Keep out of reach of children and pets.
Administration:
- Administered as an intravenous injection by a healthcare professional.
- Dose and frequency depend on the type of cancer being treated, the patient's overall health, and other medications.
- If you miss a dose, contact your healthcare provider as soon as possible.
Safety Advice:
- Not recommended for pregnant women.
- Limited information on whether Biomab EGFR 50mg Injection passes into breast milk.
- Inform your healthcare provider if you have a pre-existing lung condition or disease.
- Inform your healthcare provider if you have any liver problems or diseases.
- There are no known interactions between Biomab EGFR 50mg Injection and alcohol.
- Patients receiving Biomab EGFR 50mg Injection should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision.
Side Effects:
- Serious: allergic reactions, difficulty breathing, swelling of the face or throat, hives, infusion reactions, chest pain, irregular heartbeat, lung problems, liver problems.
- Common: skin rash, diarrhea, nausea and vomiting, fatigue, headache, fever, pain at the injection site.
FAQ:
Q1: Can Biomab EGFR 50mg Injection be used to prevent cancer? A1: Currently, Biomab EGFR 50mg Injection is only approved for cancer treatment, not prevention.
Q2: Can Biomab EGFR 50mg Injection cure cancer? A2: Biomab EGFR 50mg Injection is not a cure for cancer, but it can be an effective treatment option for certain types of solid tumors.
Q3: Can Biomab EGFR 50mg Injection be combined with other cancer treatments? A3: Yes, Biomab EGFR 50mg Injection is often combined with other cancer treatments, such as chemotherapy and radiation therapy.
Q4: Can Biomab EGFR 50mg Injection cure cancer? A4: Biomab EGFR 50mg Injection is not a cure for cancer, but it can be an effective treatment option for certain types of solid tumors.
Q5: What is the shelf life of Biomab EGFR 50mg Injection? A5: The shelf life of Biomab EGFR 50mg Injection can vary depending on the manufacturer and storage conditions.
Q6: Is Biomab EGFR 50mg Injection causing hair fall? A6: Hair loss is not a common side effect of Biomab EGFR 50mg Injection treatment.
Q7: What food should I avoid while taking Biomab EGFR 50mg Injection? A7: There are no specific foods that you need to avoid while taking Biomab EGFR 50mg Injection.
Fact Box:
- Molecule name: Nimotuzumab.
- Therapeutic class: Anticancer.
- Pharmacological class: Monoclonal Antibodies.
- Indications: Head and neck cancer, brain cancer, esophageal cancer.